SciDoc Publishers | Open Access | Science Journals | Media Partners

International Journal of Clinical Pharmacology & Toxicology (IJCPT)    IJCPT-2167-910X-08-101

A Review on Chemical Constituents and Pharmacological Properties of Hibiscus sabdariffa L.


Owoade AO*, Adetutu A, Olorunnisola OS

Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Nigeria.

*Corresponding Author

Abiodun Olusoji Owoade,
Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomosho, Nigeria.
Tel: +2348068013304
E-mail: aoowoade@lautech.edu.ng

Received: April 01, 2019; Accepted: May 10, 2019; Published: May 15, 2019

Citation: Owoade AO, Adetutu A, Olorunnisola OS. A Review on Chemical Constituents and Pharmacological Properties of Hibiscus sabdariffa L. Int J Clin Pharmacol Toxicol. 2019;8(1):300-305.

Copyright: Owoade AO© 2019. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.



Abstract

Hibiscus sabdariffa is a medicinal plant that is consumed for its health benefits, juice/concoction prepared from the plant is taken as a preventive/curative measures against diabetes and hypertension. The antihypertensive and other pharmacological properties such as antibacterial, anti-oxidant, nephro- and hepato-protective, renal/diuretic effect, anti-cholesterol, and anti-diabetic effects of Hibiscus sabdariffa have been demonstrated in several studies. Constituents of different plant parts of Hibiscus sabdariffa includes phenolic acids, organic acid, flavonoids and anthocyanins which may contribute to the pharmacological effects of the plant. Hibiscus sabdariffa is relatively safe as LD50 of its extract in rats was found to be above 5000 mg/ kg. Therefore, H. sabdariffa because of its pharmacological and nutritional benefits could be exploited in the management of various pathological conditions such as cardiovascular disease, cancer, neurological disorders and diabetes.



1.Keywords
2.Abbreviations
3.Introduction
4.Constituents of Hibiscus sabdariffa
    4.1 Organic Acids
    4.2 Anthocyanins
    4.3 Carbohydrate Content
    4.4 Lipid Content
    4.5 Polyphenols: Flavonoids and Phenolic Acids
5.Pharmacological Properties
    5.1 Effect on Blood Pressure
    5.2 Lipid-Lowering Effects
    5.3 Anticancer Effect
    5.4 Renal Effects
    5.5 Scavenging of ROS
    5.6 Effects on Endogenous Antioxidant Defences
    5.7 Effect on Smooth Muscle
    5.8 Toxicological Effect
6.Conclusion
7.References

Keywords

Hibiscus sabdariffa; Antihypertensive; Hepato-Protective; Phenolic Acids; Anthocyanins.


Abbreviations

TBARS: Thiobarbituric Acid Reactive Substances; HAs: Hibiscus Anthocyanins; HPE: Hibiscus Polyphenol-Rich Extracts; Dp3-Sam: Delphinidin 3-Sambubioside; AST: Aspartate Aminotransferase; ALT: Alanine Aminotransferase.


Introduction

There is growing market for nutraceutical and functional foods, while study on natural sources of antioxidants and their potential as nutraceutical and functional foods is on the increase [1]. One plant that have attracted much attention over the years for its health benefits is roselle (Hibiscus sabdariffa), many studies on the plant, its numerous preparation and constituents focused on its antioxidant properties. Hibiscus sabdariffa L. (roselle) belongs to the family Malvaceae. It exists as herbs or shrubs, often with fibrous stems [2]. The leaves are deeply three- to five-lobed, 8-15 cm long, arranged alternately on the stems. Vernacular names, in addition to roselle, in English-speaking regions are rozelle, sorrel, red sorrel, and Florida cranberry. In North Africa and the Near East Hibiscus sabdariffa is called karkadé or carcadé [3]. Hibiscus sabdariffa is believed to have originated from India and Malaysia, where it is commonly cultivated, and must have been carried at an early date to Africa [3]. Two main types of Hibiscus sabdariffa L. exist. The more important economically is Hibiscus sabdariffa variety altissima Wester, an erect, sparsely branched annual plant which is cultivated for its jute-like fibre in India, the East Indies, Nigeria and to some extent in tropical America. The other distinct type of roselle, Hibiscus sabdariffa variety sabdariffa, embraces shorter, bushy forms which have been described as races: bhagalpuriensi, intermedius, albus, and rubber, all breeding true from seed [3].


Figure 1. Hibiscus sabdariffa L.


In India, Africa and Mexico, all above-ground parts of the Hibiscus sabdariffa plant are valued in native medicine. Infusions of the leaves or calyces are regarded as diuretic, cholerectic, febrifugal and hypotensive, decreasing the viscosity of the blood and stimulating intestinal peristalsis. The fresh calyx of Hibiscus sabdariffa is eaten raw in salads, is cooked and used as a flavouring in cakes, presently, it is consumed worldwide as a cold beverage and as a hot drink (sour tea) [4-6]. The red anthocyanin pigments in the calyces are used as food colouring agents [7]. Seeds of Hibiscus sabdariffa are used in oily soups, sauces and coffee substitute [4, 9, 10]. Root of Hibiscus sabdariffa is edible but very fibrousy, mucilaginous, without very much flavour [10].


Constituents of Hibiscus sabdariffa

There are many published reports on the constituents of different plant parts of Hibiscus sabdariffa.

Organic Acids

Citric and malic acids are the major organic acids in aqueous extracts of the flowers of Hibiscus sabdariffa [11] this finding was collaborated by earlier works [12, 13]. Tartaric acid along with citric and oxalic acids were detected by paper chromatography in flower extracts of Hibiscus sabdariffa [14]. High concentrations of oxalic, malic, tartaric and succinic acids were also reported to be present in the calyx of Hibiscus sabdariffa with the latter predominating [15]. Khafaga and Koch [16] detected citric, hibiscus, malic and tartaric acids in the calyces of five strains of Hibiscus sabdariffa var. sabdariffa. Ascorbic acid was also reported to be present in aqueous extracts of Hibiscus sabdariffa [11, 13, 15].


Anthocyanins

Most of the chemical investigations of the flower constituents have been directed towards characterization of their pigments. Yamamoto and Oshima [18] isolated an anthocyanin, to which they assigned the structure, cyanidin-3-glucoside this was later changed to delphinidin-pentoside-glucoside [19]. Delphinidin and cyanidin were reported as major constituents of plants grown in Trinidad. These pigments were further examined by Du and Francis [20], who also isolated delphinidin-3-sambubioside (major component), delphinidin-3-monoglucoside and cyanidin-3-monoglucoside, but, in addition, characterized cyanidin-3-sambubioside as the second most abundant anthocyanin in the extract. Shibata and Furukawa [21] had earlier studied the pigments of Taiwanese roselle and reported the presence of delphinidin-3-sambubioside, along with small amounts of delphinidin-3-monoglucoside, cyanidin- 3-monoglucoside and delphinidin. More recently, anthocyanins in Hibiscus sabdariffa had been quantified with HPLC and their relative percentage determined: delphinidin-3-sambubiosidde (56%); delphinidin-3-glucoside (4%); cyanindin-3-sambubioside (33%) and cyanindin-3-glucoside (3%) [22-24].



Figure 2. Some constituents of Hibiscus sabdariffa : 1. Delphinidin-3-sambubioside, 2. Cyanidin-3-sambubioside, 3. Hibiscus protocatechuic acid, 4. Hibiscetin, 5. Gossypetin. Modified from [17].


Carbohydrate Content

The petals of Hibiscus sabdariffa was reported to yield 65% (dry weight) of mucilage, and this yielded galactose, galacturonic acid and rhamnose on hydrolysis [25]. Three water-soluble polysaccharides have been extracted from the flower buds of Hibiscus sabdariffa. The neutral compounds are composed of arabinans and arabinogalactans of low relative molecular mass. The major fraction was shown to be a pectin-like molecule (Mr = 105 Da). The main chain is composed of α-1, 4- linked galacturonic acid (24% methyl esterified) and α- 1, 2-linked rhamnose. Side chains are built of galactose and arabinose and are connected to the main chain via C-4 of every third rhamnose [26].



Table 1. The General Composition of fresh leaf of Hibiscus sabdariffa . Modified from [8].



Table 2. The General Composition of fresh fruit of Hibiscus sabdariffa . Modified from [8].


Lipid Content

The sterols of the seed oil of Hibiscus sabdariffa were studied by Salama and Ibrahim [27], who reported the presence of cholesterol, campasterol, stigmasterol, β-sitosterol, α-spinasterol and ergosterol. The seed oil has also been found to be good source of lipid-soluble antioxidant, α-tocopherol 25% γ-tocopherol 74.5% and δ-tocopherol 0.5% [28] while the component acids of the seed lipids were 2.1% myristic, 35.2% palmitic, 2.0% palmitoleic, 3.4% stearic, 34.0% oleic, 14.4% linoleic, and 3 unusual HBr-reacting fatty acids (cis-12, 13-epoxy-cis-9-octadecenoic (12,13-epoxoleic) 4.5%; sterculic, 2.9%; and malvalic, 1.3%) [29].


Polyphenols: Flavonoids and Phenolic Acids

In the last few decades there has been great interest in plant polyphenolic flavonoids and phenolic acids due to their antioxidant activity and protective effect against the development of cardiovascular disease and cancer [30, 31]. Hibiscitrin, gossypitrin and sabdaritrin have been isolated from the flower petals of Hibiscus sabdariffa. Further studies on these compounds proved Hibiscitrin to be the 3-monoglucoside of hibiscetin, and gossypitrin to be the 7-glucoside of gossypetin while sabdaritrin on acid hydrolysis, yielded hydroxyflavone sabdaretin [32, 33]. Owoade et al., [34] (2016), using TLC, HPLC and LCMS analysis showed the presence of ferulic acid, chlorogenic acid, naringenin, rutin and quercetin in Hibiscus sabdariffa extracts. Also, protocatechuic acid, catechin, epigallocatechin, epigallocatechin gallate and caffeic acid have been identified with HPLC in an extract of Hibiscus sabdariffa [34, 35]. Earlier workers have also isolated protocatechuic acid [36], eugenol [37] and quercetin [38] in Hibiscus sabdariffa.


Pharmacological Properties

Effect on Blood Pressure

Intravenous injection of aqueous extracts of Hibiscus sabdariffa calyx to anaesthetized cats [39] and anaesthetized rats [40] lowered blood pressure in a dose-dependent manner. More recently, the antihypertensive action of Hibiscus sabdariffa has been confirmed in rats with experimental hypertension [41, 42] and in spontaneously hypertensive rats [43] given the aqueous extracts at doses of 250-1000 mg/kg for up to 14 weeks. Dietary supplementation with Hibiscus sabdariffa has been shown to have blood pressure reducing effects in patients with moderate essential hypertension, [44-46]. This hypotensive action of Hibiscus sabdariffa extracts was due to inhibition of angiotensin-converting enzyme [46, 47]. The inhibition of angiotensin-converting enzyme has also been demonstrated in vitro with a crude hydroethanol extract of Hibiscus sabdariffa calyces, and was ascribed to flavones present in the extract. In addition, a beneficial cardioprotective effect of this extract was shown in vivo, and was attributed to flavonoids and anthocyanins [47].


Lipid-Lowering Effects

Blood lipids and lipoproteins circulating in the blood in the form of LDL are decreased in response to treatment with Hibiscus sabdariffa. Ethanol extract of Hibiscus sabdariffa has been shown to reduce cholesterol, VLDL-cholesterol and LDL-cholesterol in alloxan - diabetic rats [48]. Dietary supplementation with Hibiscus sabdariffa was effective in lowering serum concentrations of triglycerides, total cholesterol and LDL-cholesterol in hypercholesterolemic rabbits [49], and hypercholesterolemic rats. In addition, thiobarbituric acid reactive substances (TBARs) and conjugated dienes formed during oxidation of LDL by CuSO4, CCl4 were reduced [50, 51]. Similar study using Hibiscus anthocyanins (HAs) extracts shown the extracts decrease the relative electrophoretic mobility of oxLDL, inhibit fragmentation of Apo B, reduced TBARS formation in the Cu2+-mediated oxidize LDL and scavenge over 95% of free DPPH radicals [52]. Lipid fractions in plasma, heart, brain, kidney and liver were lowered in hypercholesterolaemia rats fed with Hibiscus sabdariffa calyx (5% or 10%) for 9 weeks [53].


Anticancer Effect

in vitro studies have shown that Hibiscus sabdariffa extracts can induce apoptosis in cancer cells. Hibiscus polyphenol-rich extracts (HPE) induce cell death in human gastric carcinoma (AGS) in a concentration-dependent manner [35, 54], this effect of HPE on AGS cells was mediated via p53 signaling and p38 MAPK/ FasL cascade pathway [35]. Also, Hibiscus anthocyanins extract (a group of natural pigments existing in the dried calyx of Hibiscus sabdariffa L.) caused cancer cell apoptosis, in HL-60 cells [55, 56], similarly Delphinidin 3-sambubioside (Dp3-Sam), isolated from the dried calices of Hibiscus sabdariffa L induce apoptosis in human leukemia cells (HL-60) [57]. Anticlastogenic effects of Hibiscus sabdariffa extract has been demonstrated against sodium arsenite-induced micronuclei formation in erythrocytes in mouse bone marrow [58]. Various studies on Hibiscus protocatechuic acid has demonstrated its ability to inhibit the carcinogenic action of various chemicals in different tissues of the rat, including diethyl nitrosamine in the liver [59], 4-nitroquinoline-1-oxide in the oral cavity [60], azoxymethane in the colon [61], N-methyl- N-nitrosourea in glandular stomach tissue [62] and Nbutyl- N-(4- hydroxybutyl) nitrosamine in the bladder [63]. Tseng et al., [64] also demonstrated that Hibiscus protocatechuic acid inhibits the survival of human promyelocytic HL-60 cells in a concentrationand time-dependent manner. The data presented by Tseng et al., [64] suggest that the compound is an apoptosis inducer in human leukaemia cells and that RB phosphorylation and Bcl-2 protein may play a crucial role in the early stage.


Renal Effects

Oral administration of Hibiscus sabdariffa extracts significantly normalizes the level of ammonia, urea, uric acid, creatinine and non-protein nitrogen in the blood of ammonium chlorideinduced hyperammonemic rats [65]. Consumption of Hibiscus sabdariffa extract in normal human subject significantly decreased the urinary concentrations of creatinine, uric acid, citrate, tartrate, calcium, sodium, potassium and phosphate, but not oxalate [66]. Also, low dose of Hibiscus sabdariffa (16 g/day) caused a more significant decrease in salt output in the urine than a high dose (24 g/day) [66]. Dietary supplementation with dried calyx of Hibiscus sabdariffa in rats resulted in a significant uricosuric action [67, 68].


Scavenging of ROS

Hibiscus sabdariffa extracts and its constituents, Protocatechuic acid, anthocyanins demonstrated the ability to scavenge the 1, 1- diphenyl-2-picrylhydazyl (DPPH) and 2,2-azino-bis (3- ethylbenzthiazoline- 6-sufonic acid) (ABTS) free radicals using a cell free system [24, 51, 52]. Hibiscus sabdariffa extracts and its constituents have also been observed to scavenge the t-butyl hydroperoxide radical and hence prevent oxidative damage in rat primary hepatocytes [5, 36, 69]. The extracts have been shown to scavenge hydroxyl radical (OH•) and Hydrogen peroxide (H2O2) [71]. The extracts also showed strong inhibitory effect on xanthine oxidase activity and superoxide (•O2‾) radical [69, 72]. Hibiscus protocatechuic acid isolated from Hibiscus sabdariffa inhibits lipopolysaccharide- induced rat hepatic damage [73] and inhibits oxidation of low-density lipoprotein induced by either copper or a nitric acid donor [74]. Hibiscus sabdariffa anthocyanins were effective in significantly mitigating the pathotoxicity induced by paracetamol in mice [75], it also protects against DNA damage induced by tert-butyl hydroperoxide in rat smooth muscle and hepatoma cells [76]. In view of the established strong antioxidant and antilipid peroxidation actions of Hibiscus sabdariffa extracts and the compounds they contain [5, 69, 77], anthocyanins and Hibiscus protocatechuic acid may potentially be useful in ameliorating or preventing these diseases and conditions.


Effects on Endogenous Antioxidant Defences

Dietary supplementations with Hibiscus sabdariffa extracts has been shown to significantly reduce carbon tetrachloride (CCl4) induced liver damage in rats [51, 78], acetaminophen and Fe2+ induced liver damage in mice and rats [79] and cadmium induce liver toxicity [80]. Also, aqueous extracts of Hibiscus sabdariffa demonstrated protective effect against azathioprine-induced hepatotoxicity. Animals pre-treated with the extracts not only failed to show necrosis of the liver after azathioprine administration, but also retained livers that, for the most part, were histologically normal [81]. In all studies Hibiscus sabdariffa extracts significantly decreased the elevation of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in plasma [51, 78-81]. In a similar study oral administration of the ethanol extracts of Hibiscus sabdariffa significantly decreased sodium arsenite - induced malondialdehyde (MDA) formation in rat’s liver, the extract also attenuated sodium arsenite induced reduction in the serum level of vitamin C [82]. In all these studies it was demonstrated that pre-treatment of animal with Hibiscus sabdariffa extracts prevented GSH depletion, while other endogenous antioxidant enzymes (SOD, catalase and glutathione peroxidase) activity were increased couple with decrease in lipid peroxidation [65, 78, 81, 82].


Effect on Smooth Muscle

Hibiscus sabdariffa have been shown to have relaxation effect on the smooth muscles, and this has been proposed to be partially responsible for its hypotensive action [83]. The extracts of Hibiscus sabdariffa calyces inhibited the tone of various isolated muscle preparations that included rabbit and rat aortic strip [83, 84] and rat ileal strip [85]. The extract also rhythmically contracted rat uterus, guinea-pig tracheal chain and rat diaphragm. The same extract stimulated quiescent rat uterus and frog rectus abdominus muscle [39, 86]. The tonic effects on rat uterus were partially reduced by hydrocortisone and indomethacin. The overall effect is a direct relaxation of the smooth muscles. The relaxant response was related to endothelium-dependent and endothelium-independent mechanisms [84], or mediated through calcium channels, possibly generated by constituents such as quercetin and eugenol [83, 85]. However, the presence of stimulatory substance(s) in the extract has also been demonstrated using the frog rectus abdominus preparation [39].


Toxicological Effect

The extract of H. sabdariffa was found to be relatively and virtually non-toxic with LD50 in rats to be above 5000 mg/kg [43].


Conclusion

The information from in vitro and in vivo studies shows a wide range of potentially new health applications and therapeutic targets for Hibiscus sabdariffa. H. sabdariffa is relatively safe and virtually nontoxic. Many pharmacological properties of H. sabdariffa may be attributed to the presence of a plethora of phytochemicals in the plant. The potent antioxidant activity of Hibiscus sabdariffa may be linked to the presence different antioxidants compounds with differing sites and mechanisms of action which may act alone or in concert with one another. Therefore, dietary supplementation of Hibiscus sabdariffa plant extract may be beneficial in reducing the risk of developing various pathological conditions such as cardiovascular disease, cancer, neurological disorders and diabetes.


References

  1. Cevallos-Casals BA, Cisneros-Zevallos L. Stoichiometric and kinetic studies of phenolic antioxidants from Andean purple corn and red-fleshed sweetpotato. J Agric Food Chem. 2003 May 21;51(11):3313-9. PubMed PMID: 12744660.
  2. Eno. Zobo so fine but; Success Digest (Nigeria No1 Life changing Magazine); 2000.
  3. Morton JF. Fruits of warm climates. JF Morton; 1987. p.281-286.
  4. Facciola S. Cornucopia: a source book of edible plants. Kampong Publications ;1990.
  5. Wang CJ, Wang JM, Lin WL, Chu CY, Chou FP, Tseng TH. Protective effect of Hibiscus anthocyanins against tert-butyl hydroperoxide-induced hepatic toxicity in rats. Food Chem Toxicol. 2000 May;38(5):411-6. PubMed PMID: 10762726.
  6. Ross IA. Hibiscus sabdariffa. In Medicinal plants of the world. Humana Press, Totowa, NJ; 2003. p. 267-275.
  7. Esselen WB, Sammy GM. Applications for roselle as a red food colorant. Food Prod Dev. 1975:80-82.
  8. Duke J. Handbook of Energy Crops. Published only on the Internet, excellent information on a wide range of plants. 1983.
  9. Kunkel G. Plants for human consumption. Koeltz Scientific Books; 1984.
  10. Cribb AB, Cribb JW. Wild food in Australia. Collins; 1974.
  11. Buogo G, Picchinenna D. Chemical characteristics of Roselle hemp. Ann Chim Appl. 1937;27:577-82.
  12. Indovina R, Capotummino G. Chemical analysis of karkade, the extract derived from Hibiscus sabdariffa L. cultivated in Sicily (Palermo). Ann Chim Appl. 1938;28:413-8.
  13. Reaubourg G, Monceaux RH. The chemical, botanical and pharmacological characteristics of the karkade (rosella) Hibiscus sabdariffa (gossypifolius). J Pharm Chim. 1940;1(9):292.
  14. Lin YC. Study of red pigments in Taiwan plants. Proc Natl Sci Counc. 1975.
  15. Wong PK, Yusof S, Ghazali HM, Che Man YB. Physico-chemical characteristics of roselle (Hibiscus sabdariffa L.). Nutr Food Sci. 2002 Apr 1;32(2):68- 73.
  16. Khafaga ER, Koch H. Stage of maturity and quality of roselle (Hibiscus sabdariffa var. sabdariffa). II. Anthocyanins. Angewandte Botanik. 1980;54(5/6):295-300.
  17. Ali BH, Wabel NA, Blunden G. Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.: a review. Phytother Res. 2005 May;19(5):369-75. PubMed PMID: 16106391.
  18. Yamamoto R, Oshima T. Red coloring matter of Hibiscus sabdariffa L. (A new glucoside, hibiscin). Science Papers Institute of Physics and Chemistry Research (Tokyo). 1932;19:134-141.
  19. Yamamoto R. On the Colouring Matter of" Hibiscus sabdariffa" L.(Hiviscin). II. By Ryo Yamamoto and Yasuyosi Osima. Institute of physical and chemical research; 1936.
  20. Du CT, Francis FJ. Anthocyanins of roselle (Hibiscus sabdariffa, L.). J Food Sci. 1973 Jul;38(5):810-2.
  21. Shibata M, Furukawa M. Re examination on the structure of so-called “Hiviscin”. Shokubutsugaku Zasshi. 1969;82(974-975):341-7.
  22. Hong V, Wrolstad RE. Use of HPLC separation/photodiode array detection for characterization of anthocyanins. J Agric Food Chem. 1990 Mar;38(3):708-15.
  23. Sukwattanasinit T, Burana-Osot J, Sotanaphun U. Spectrophotometric method for quantitative determination of total anthocyanins and quality characteristics of roselle (Hibiscus sabdariffa). Planta Med. 2007 Nov;73(14):1517-22. PubMed PMID: 17992627.
  24. Owoade AO, Lowe GM, Khalid R. The in vitro antioxidant properties of Hibiscus anthocyanins rich extract (HAE). Nat Sci. 2015;13(3):22-29.
  25. El-Hamidi A, Saleh M, Ahmed SS. Hibiscus sabdariffa. J Chem UAR. 1966;9:127.
  26. Müller BM, Franz G. Chemical structure and biological activity of polysaccharides from Hibiscus sabdariffa. Planta Med. 1992 Feb;58(1):60-7. Pub- Med PMID: 1620746.
  27. Salama RB, Ibrahim SA. Ergosterol in Hibiscus sabdariffa seed oil. Planta Medica. 1979 Jul;36(07):221-2.
  28. Mohamed R, Fernandez J, Pineda M, Aguilar M. Roselle (Hibiscus sabdariffa) seed oil is a rich source of γ‐Tocopherol. J Food Sci. 2007 Apr;72(3):S207-11. PubMed PMID: 17995816.
  29. Ahmed WK, Hudson JB. The fatty acid composition of Hibiscus sabdariffa seed oil. J Sci Food Agric. 1982 Dec;33(12):1305-9.
  30. Schroeter H, Boyd C, Spencer JP, Williams RJ, Cadenas E, Rice-Evans C. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging. 2002 Sep-Oct;23(5):861-80. PubMed PMID: 12392791.
  31. Fraga CG. Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions. IUBMB life. 2007;59(4‐5):308-15.
  32. Rao PR, Seshadri TR. Constitution of hibiscitrin. Part I. In Proceedings of the Indian Academy of Sciences-Section A. 1948 Mar 1;27:104–216.
  33. Rao PS, Seshadri TR. Pigments of the flowers of Hibiscus sabdariffa. In Proceedings of the Indian Academy of Sciences-Section A. 1942 Nov 1;16:323- 327.
  34. Owoade AO, Adetutu A, Olorunnisola OS. Identification of Phenolic Compounds in Hibiscus sabdariffa Polyphenolic Rich Extract (HPE) by Chromatography Techniques. Br J Pharm Res. 2016 Jan 1;12(4).
  35. Lin HH, Huang HP, Huang CC, Chen JH, Wang CJ. Hibiscus polyphenol‐ rich extract induces apoptosis in human gastric carcinoma cells via p53 phosphorylation and p38 MAPK/FasL cascade pathway. Mol Carcinog. 2005 Jun;43(2):86-99. PubMed PMID: 15791651.
  36. Tseng TH, Wang CJ, Kao ES. Hibiscus protocatechuic acid protects against oxidative damage induced by tert-butylhydroperoxide in rat primary hepatocytes. Chem Biol Interact. 1996 Aug 14;101(2):137-48. PubMed PMID: 8760395.
  37. Chen SH, Huang TC, Ho CT, Tsai PJ. Extraction, analysis, and study on the volatiles in roselle tea. J Agric Food Chem. 1998 Mar 16;46(3):1101-5.
  38. Takeda N, Yasui Y. Identification of mutagenic substances in roselle color, elderberry color and safflower yellow. Agric Biol Chem. 1985;49(6):1851-2.
  39. Ali MB, Salih WM, Mohamed AH, Homeida AM. Investigation of the antispasmodic potential of Hibiscus sabdariffa calyces. J Ethnopharmacol. 1991 Feb;31(2):249-57. PubMed PMID: 2023432.
  40. Adegunloye BJ, Omoniyi JO, Owolabi OA, Ajagbonna OP, Sofola OA, Coker HA. Mechanisms of the blood pressure lowering effect of the calyx extract of Hibiscus sabdariffa in rats. Afr J Med Med Sci. 1996 Sep;25(3):235-8. PubMed PMID: 10457797.
  41. Odigie IP, Ettarh RR, Adigun SA. Chronic administration of aqueous extract of Hibiscus sabdariffa attenuates hypertension and reverses cardiac hypertrophy in 2K-1C hypertensive rats. J Ethnopharmacol. 2003 Jun;86(2-3):181-5. PubMed PMID: 12738084.
  42. Mojiminiyi FB, Dikko M, Muhammad BY, Ojobor PD, Ajagbonna OP, Okolo RU, et al. Antihypertensive effect of an aqueous extract of the calyx of Hibiscus sabdariffa. Fitoterapia. 2007 Jun;78(4):292-7. PubMed PMID: 17482378.
  43. Onyenekwe PC, Ajani EO, Ameh DA, Gamaniel KS. Antihypertensive effect of roselle (Hibiscus sabdariffa) calyx infusion in spontaneously hypertensive rats and a comparison of its toxicity with that in Wistar rats. Cell Biochem Funct. 1999 Sep;17(3):199-206. PubMed PMID: 10451541.
  44. Faraji MH, Tarkhani AH. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmacol. 1999 Jun;65(3):231-6. PubMed PMID: 10404421.
  45. Herrera-Arellano A, Flores-Romero S, Chavez-Soto MA, Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine. 2004 Jul;11(5):375-82. PubMed PMID: 15330492.
  46. Herrera-Arellano A, Miranda-Sánchez J, Ávila-Castro P, Herrera-Álvarez S, Jiménez-Ferrer JE, Zamilpa A, et al. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Med. 2007 Jan;73(1):6-12. PubMed PMID: 17315307.
  47. Jonadet M, Bastide J, Bastide P, Boyer B, Carnat AP, Lamaison JL. in vitro enzyme inhibitory and in vivo cardioprotective activities of hibiscus (Hibiscus sabdariffa L.). J Pharm Belg. 1990 Mar-Apr;45(2):120-4. PubMed PMID: 2355305.
  48. Farombi EO, Ige OO. Hypolipidemic and antioxidant effects of ethanolic extract from dried calyx of Hibiscus sabdariffa in alloxan‐induced diabetic rats. Fundam Clin Pharmacol. 2007 Dec;21(6):601-9. PubMed PMID: 18034661.
  49. Chen CC, Hsu JD, Wang SF, Chiang HC, Yang MY, Kao ES, et al. Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterolfed rabbits. J Agric Food Chem. 2003 Aug 27;51(18):5472-7. PubMed PMID: 12926900.
  50. Hirunpanich V, Utaipat A, Morales NP, Bunyapraphatsara N, Sato H, Herunsale A, et al. Hypocholesterolemic and antioxidant effects of aqueous extracts from the dried calyx of Hibiscus sabdariffa L. in hypercholesterolemic rats. J Ethnopharmacol. 2006 Jan 16;103(2):252-60. PubMed PMID: 16213683.
  51. Owoade OA, Adetutu A. Antioxidant and hepatoprotective effect of Hibiscus sabdariffa Methanolic Extract (HME) against carbon tetrachloride (CCL4) induced damage in Rats. Researcher. 2015;7:64-72.
  52. Chang YC, Huang KX, Huang AC, Ho YC, Wang CJ. Hibiscus anthocyanins- rich extract inhibited LDL oxidation and oxLDL-mediated macrophages apoptosis. Food Chem Toxicol. 2006 Jul;44(7):1015-23. PubMed PMID: 16473450.
  53. El‐Saadany SS, Sitohy MZ, Labib SM, El‐Massry RA. Biochemical dynamics and hypocholesterolemic action of Hibiscus sabdariffa (Karkade). Nahrung. 1991;35(6):567-76. PubMed PMID: 1787844.
  54. Lin HH, Chen JH, Kuo WH, Wang CJ. Chemopreventive properties of Hibiscus sabdariffa L. on human gastric carcinoma cells through apoptosis induction and JNK/p38 MAPK signaling activation. Chem Biol Interact. 2007 Jan 5;165(1):59-75. PubMed PMID: 17145051.
  55. Chang YC, Huang HP, Hsu JD, Yang SF, Wang CJ. Hibiscus anthocyanins rich extract-induced apoptotic cell death in human promyelocytic leukemia cells. Toxicol Appl Pharmacol. 2005 Jun 15;205(3):201-12. PubMed PMID: 15922006.
  56. Sowemimo AA, Fakoya FA, Awopetu I, Omobuwajo OR, Adesanya SA. Toxicity and mutagenic activity of some selected Nigerian plants. J Ethnopharmacol. 2007 Sep 25;113(3):427-32. PubMed PMID: 17707603.
  57. Hou DX, Tong X, Terahara N, Luo D, Fujii M. Delphinidin 3-sambubioside, a Hibiscus anthocyanin, induces apoptosis in human leukemia cells through reactive oxygen species-mediated mitochondrial pathway. Arch Biochem Biophys. 2005 Aug 1;440(1):101-9. PubMed PMID: 16018963.
  58. Adetutu A, Odunola OA, Owoade OA, Adeleke OA, Amuda OS. Anticlastogenic effects of Hibiscus sabdariffa fruits against sodium arsenite‐induced micronuclei formation in erythrocytes in mouse bone marrow. Phytother Res. 2004 Oct;18(10):862-4. PubMed PMID: 15551375.
  59. Tanaka T, Kojima T, Kawamori T, Yoshimi N, Mori H. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Cancer Res. 1993 Jun 15;53(12):2775-9. PubMed PMID: 8504418.
  60. Tanaka T, Kawamori T, Ohnishi M, Okamoto K, Mori H, Hara A. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases. Cancer Res. 1994 May 1;54(9):2359-65. PubMed PMID: 8162581.
  61. Kawamori T, Tanaka T, Kojima T, Suzui M, Ohnishi M, Mori H. Suppression of azoxymethane‐induced rat colon aberrant crypt foci by dietary protocatechuic acid. Jpn J Cancer Res. 1994 Jul;85(7):686-91. PubMed PMID: 8071110.
  62. Tanaka T, Kojima T, Kawamori T, Mori H. Chemoprevention of digestive organs carcinogenesis by natural product protocatechuic acid. Cancer. 1995 Mar 15;75(6 Suppl):1433-9. PubMed PMID: 7889470.
  63. Hirose Y, Tanaka T, Kawamori T, Olnishi M, Makita H, Mori H, et al. Chemoprevention of urinary bladder carcinogenesis by the natural phenolic compound protocatechuic acid in rats. Carcinogenesis. 1995 Oct;16(10):2337-42. PubMed PMID: 7586132.
  64. Tseng TH, Kao TW, Chu CY, Chou FP, Lin WL, Wang CJ. Induction of apoptosis by hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression. Biochem Pharmacol. 2000 Aug 1;60(3):307-15. PubMed PMID: 10856425.
  65. Essa MM, Subramanian P. Hibiscus sabdariffa affects ammonium chlorideinduced hyperammonemic rats. Evid Based Complement Alternat Med. 2007 Sep;4(3):321-5. PubMed PMID: 17965762.
  66. Kirdpon S, Nakorn SN, Kirdpon W. Changes in urinary chemical composition in healthy volunteers after consuming roselle (Hibiscus sabdariffa Linn.) juice. J Med Assoc Thai. 1994 Jun;77(6):314-21. PubMed PMID: 7869018.
  67. Cáceres A, Girón LM, Martínez AM. Diuretic activity of plants used for the treatment of urinary ailments in Guatemala. J Ethnopharmacol. 1987 May;19(3):233-45. PubMed PMID: 3669686.
  68. Mojiminiyi FB, Adegunloye BJ, Egbeniyi YA, Okolo RU. An investigation of the diuretic effect of an aqueous extract of the petals of Hibiscus sabdariffa. J Med Med Sci. 2000;2:77-80.
  69. Tseng TH, Kao ES, Chu CY, Chou FP, Wu HW, Wang CJ. Protective effects of dried flower extracts of Hibiscus sabdariffa L. against oxidative stress in rat primary hepatocytes. Food Chem Toxicol. 1997 Dec;35(12):1159-64. PubMed PMID: 9449221.
  70. Liu CL, Wang JM, Chu CY, Cheng MT, Tseng TH. in vivo protective effect of protocatechuic acid on tert-butyl hydroperoxide-induced rat hepatotoxicity. Food Chem Toxicol. 2002 May;40(5):635-41. PubMed PMID: 11955669.
  71. Farombi EO, Fakoya A. Free radical scavenging and antigenotoxic activities of natural phenolic compounds in dried flowers of Hibiscus sabdariffa L. Mol Nutr Food Res. 2005 Dec;49(12):1120-8. PubMed PMID: 16254885.
  72. Owoade AO, Adetutu A, Olorunnisola OS. Antioxidant Potential of Polyphenol Rich Extract from Hibiscus sabdariffa. Br J Med Med Res. 2016;16(4):1-0.
  73. Lin WL, Hsieh YJ, Chou FP, Wang CJ, Cheng MT, Tseng TH. Hibiscus protocatechuic acid inhibits lipopolysaccharide-induced rat hepatic damage. Arch Toxicol. 2003 Jan;77(1):42-7. PubMed PMID: 12491040.
  74. Lee MJ, Chou FP, Tseng TH, Hsieh MH, Lin MC, Wang CJ. Hibiscus protocatechuic acid or esculetin can inhibit oxidative LDL induced by either copper ion or nitric oxide donor. J Agric Food Chem. 2002 Mar 27;50(7):2130-6. PubMed PMID: 11902968.
  75. Ali BH, Mousa HM, El‐Mougy S. The effect of a water extract and anthocyanins of Hibiscus sabdariffa L. on paracetamol‐induced hepatoxicity in rats. Phytother Res. 2003 Jan;17(1):56-9. PubMed PMID: 12557248.
  76. Lazze MC, Pizzala R, Savio M, Stivala LA, Prosperi E, Bianchi L. Anthocyanins protect against DNA damage induced by tert-butyl-hydroperoxide in rat smooth muscle and hepatoma cells. Mutat Res. 2003 Feb 5;535(1):103-15. PubMed PMID: 12547288.
  77. Suboh SM, Bilto YY, Aburjai TA. Protective effects of selected medicinal plants against protein degradation, lipid peroxidation and deformability loss of oxidatively stressed human erythrocytes. Phytother Res. 2004 Apr;18(4):280-4. PubMed PMID: 15162361.
  78. Liu JY, Chen CC, Wang WH, Hsu JD, Yang MY, Wang CJ. The protective effects of Hibiscus sabdariffa extract on CCl4-induced liver fibrosis in rats. Food Chem Toxicol. 2006 Mar;44(3):336-43. PubMed PMID: 16176854.
  79. Olaleye MT, Rocha BJ. Acetaminophen-induced liver damage in mice: effects of some medicinal plants on the oxidative defense system. Exp Toxicol Pathol. 2008 Mar;59(5):319-27. PubMed PMID: 18054472.
  80. Asagba SO, Adaikpoh MA, Kadiri H, Obi FO. Influence of aqueous extract of Hibiscus sabdariffa L. petal on cadmium toxicity in rats. Biol Trace Elem Res. 2007 Jan;115(1):47-57. PubMed PMID: 17406073.
  81. Amin A, Hamza AA. Hepatoprotective effects of Hibiscus, Rosmarinus and Salvia on azathioprine-induced toxicity in rats. Life Sci. 2005 Jun 3;77(3):266-78. PubMed PMID: 15878355.
  82. Usoh IF, Akpan EJ, Etim EO, Farombi EO. Antioxidant actions of dried flower extracts of Hibiscus sabdariffa L. on sodium arsenite-induced oxidative stress in rats. Pakistan J Nutr. 2005;4(3):135-41.
  83. Ajay M, Chai HJ, Mustafa AM, Gilani AH, Mustafa MR. Mechanisms of the anti-hypertensive effect of Hibiscus sabdariffa L. calyces. J Ethnopharmacol. 2007 Feb 12;109(3):388-93. PubMed PMID: 16973321.
  84. Obiefuna PC, Owolabi OA, Adegunloye BJ, Obiefuna IP, Sofola OA. The petal extract of Hibiscus sabdariffa produces relaxation of isolated rat aorta. Int J Pharmacogn . 1994 Jan 1;32(1):69-74.
  85. Salah AM, Gathumbi J, Vierling W. Inhibition of intestinal motility by methanol extracts of Hibiscus sabdariffa L.(Malvaceae) in rats. Phytother Res. 2002 May;16(3):283-5. PubMed PMID: 12164279.
  86. Fouda AM, Daba MH, Dahab GM. Inhibitory effects of aqueous extract of Hibiscus sabdariffa on contractility of the rat bladder and uterus. Can J Physiol Pharmacol. 2007 Oct;85(10):1020-31. PubMed PMID: 18066103.


         Indexed in

pubhub  CGS  indexcoop  
j-gate  DOAJ  Google_Scholar_logo

       Total Visitors

SciDoc Counter

Get in Touch

SciDoc Publishers
16192 Coastal Highway
Lewes, Delaware 19958
Tel :+1-(302)-703-1005
Fax :+1-(302)-351-7355
Email: contact.scidoc@scidoc.org


porn